PORTLAND, Ore., August 27, 2019 – Nobilis Therapeutics announced today the issuance of the United States patent filed by the company in May of 2017. The patent number 10,376,539, titled “”AUGMENTATION OF ANTIINFLAMMATORY, IMMUNOMODULATORY, AND REGENERATIVE PROCESSES IN AMYOTROPHIC LATERAL SCLEROSIS USING XENON AND NOBLE GAS COMBINATIONS” covers the use of noble gases for the treatment of ALS.

“We are very excited to receive this patent,” said Dr. Vlad Bogin, company’s CEO. “ALS is a devastating and untreatable disease and we would be elated if we could provide symptomatic relief to patients in need. We will be beyond overjoyed if our approach demonstrates even modest disease-modifying properties. This patent is one in a series of applications that stem from the extensive proprietary data generated by our talented research team that we have collected and analyzed. It is yet another step for the company towards securing the use of subanesthetic doses of noble gases to treat a variety of psychiatric and neurodegenerative diseases.”

“We are very interested in anti-inflammatory, antiapoptotic as well as anxiolytic and analgesic properties of xenon-based treatment, which is a very appealing combination for patients with ALS. As we progress with our clinical programs, we would love to study this approach in clinic,” said Dr. Alexander Dobrovolsky, MD, Ph.D., company’s core expert.

About Nobilis Therapeutics, Inc.

Nobilis Therapeutics is a biotechnology company that is focused on development and commercialization of proprietary inhalation-based treatments using controlled device administration of inert gases that have an exceptional safety profile proven by decades of clinical use. The Company has filed multiple patents on the use of inert gases for treatment of a variety of psychiatric and neurodegenerative diseases and leverages the experience of its international team that has successfully used this technology in the treatment of over 2000 patients for conditions ranging from panic attacks to substance abuse.

Contact Information:

Vlad Bogin, MD, FACP

3042 NW Monte Vista Terrace

​Portland, OR 97210

​Tel: (971) 229-1679

​Email: vbogin@nobilistx.com

​Website: http://www.nobilistx.com

​Twitter: @nobilistx